Results 111 to 120 of about 3,193,785 (231)

Accuracy of Accuhaler, Ellipta, and Turbuhaler Testers in Patients with Chronic Obstructive Pulmonary Disease. [PDF]

Med Sci (Basel)
Saiphoklang N, Siriyothipun T, Panichaporn S.   +2 more
europepmc   +1 more source

Ensifentrine: A Novel Option for Maintenance of Chronic Obstructive Pulmonary Disease. [PDF]

J Pharm Technol
Hitt EM, Powell AJ.
europepmc   +1 more source

Relation of Changes in PEF and FEV₁ During Salbutamol-Induced Bronchodilation After Methacholine Challenge Test. [PDF]

Pulm Med
Csonka LL, Tikkakoski A, Vuotari L, Karjalainen J, Lehtimäki L.   +4 more
europepmc   +1 more source

On-the-spot spirometry & combined salbutamol & glycopyrronium reversibility testing in obstructive airway disease: A real-world appraisal. [PDF]

Indian J Med Res
Bhattacharyya P, Sen S, Ghosh S, Dey D, Sengupta S, Karmakar S, Saha D, Kar A, Banerjee R.   +8 more
europepmc   +1 more source

Drivers of Bronchodilator Use in Bronchiolitis: Analyzing Treatment Trends From Pediatric Emergency Department Practices. [PDF]

Pediatr Emerg Care
Rivera-Sepulveda A, Maul T, Jurlina A, Blake KV, Davis MM, Alexander K.   +5 more
europepmc   +1 more source

Mast cell stabilising agents compared to short acting bronchodilating agents to prevent exercise-induced bronchoconstriction [PDF]

BMC News and views, 2001
Carol Spooner, Brian H. Rowe, G. Richard Spooner   +2 more
openaire   +1 more source

Predictors of Clinical Stability and Mortality in COPD: A Longitudinal Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Loo WTW, Chew SY, Tan JHY, Soh RY, Koh MS, Lapperre TS, Tiew PY.   +6 more
europepmc   +1 more source

Clinical characteristics of asthma-chronic obstructive pulmonary disease overlap phenotypes. [PDF]

Postepy Dermatol Alergol
Atik Ö, Merve Tepetam F, Özden Ş, Ezgi Ak A.   +3 more
europepmc   +1 more source

Advancing Obstructive Airway Disease Treatment: Dual PDE3/4 Inhibition as a Therapeutic Strategy. [PDF]

Cells
Sherpa RT, Koziol-White CJ, Panettieri RA.   +2 more
europepmc   +1 more source

Efficacy and Safety of Biologics Targeting Type 2 Inflammation in COPD: A Systematic Review and Network Meta-Analysis. [PDF]

Int J Chron Obstruct Pulmon Dis
Li S, Yi B, Wang H, Xu X, Yu L.
europepmc   +1 more source